Expression of neurotrophic factors in diabetic muscle-relation to neuropathy and muscle strength

Brain

Volumn 132, Issue 10, 2009, Pages 2724-2733

  Andreassen, C S ^a   Jakobsen, J ^a   Flyvbjerg, A ^a   Andersen, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetic polyneuropathy; Human; Muscle strength; Neurotrophic factor; Striated muscle

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DYNAMOMETRY; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE STRENGTH; NERVE CONDUCTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIBRATION SENSE;

ADULT; AGED; BIOPSY; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCLE, STRIATED; NERVE GROWTH FACTORS; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHWANN CELLS; VIBRATION;

EID: 70349928563     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp208     Document Type: Article

References (53)

1. Amano T, Yamakuni T, Okabe N, Sakimura K, Takahashi Y. Production of nerve growth factor in rat skeletal muscle. Neurosci Lett 1991; 132: 5-7.
2. Anand P, Terenghi G, Birch R, Wellmer A, Cedarbaum JM, Lindsay RM, et al. Endogenous NGF and CNTF levels in human peripheral nerve injury. Neuroreport 1997; 8: 1935-1938
3. Andersen H. Reliability of isokinetic measurements of ankle dorsal and plantar flexors in normal subjects and in patients with peripheral neuropathy. Arch Phys Med Rehabil 1996a; 77: 265-268
4. Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 2004a; 27: 2382-2385
5. Andersen H, Poulsen PL, Mogensen CE, Jakobsen J. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 1996b; 45: 440-445
6. Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 1997; 40: 1062-1069
7. Andersen H, Stalberg E, Gjerstad MD, Jakobsen J. Association of muscle strength and electrophysiological measures of reinnervation in diabetic neuropathy. Muscle Nerve 1998; 21: 1647-1654
8. Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004b; 53: 1543-1548
9. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006; 55: 806-812
10. Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles-a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia 2009; 52: 1182-1191
11. Apfel SC, Arezzo JC, Moran M, Kessler JA. Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheral nerves in vivo. Brain Res 1993; 604: 1-6.
12. Copray S, Liem R, Brouwer N, Greenhaff P, Habens F, Fernyhough P. Contraction-induced muscle fiber damage is increased in soleus muscle of streptozotocin-diabetic rats and is associated with elevated expression of brain-derived neurotrophic factor mRNA in muscle fibers and activated satellite cells. Exp Neurol 2000; 161: 597-608.
13. Davis S, Aldrich TH, Valenzuela DM, Wong VV, Furth ME, Squinto SP, et al. The receptor for ciliary neurotrophic factor. Science 1991; 253: 59-63.
14. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003; 29: 211-230
15. De Carrizosa MA, Morado-Diaz CJ, Tena JJ, Benitez-Temino B, Pecero ML, Morcuende SR, et al. Complementary actions of BDNF and neurotrophin-3 on the firing patterns and synaptic composition of motoneurons. J Neurosci 2009; 29: 575-587
16. Dyck PJ. Quantitating severity of neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia, PA: W.B. Saunders; 1993a. p. 686-697
17. Dyck PJ, O?Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 1993b; 43: 1508-1512
18. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O?Brien PC, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987; 10: 432-440
19. English AW. Cytokines, growth factors and sprouting at the neuro-muscular junction. J Neurocytol 2003; 32: 943-960
20. Falck B, Stalberg E, Bischoff C. Sensory nerve conduction studies with surface electrodes. Methods Clin Neurophysiol 1994; 5: 1-20.
21. Fernyhough P, Maeda K, Tomlinson DR. Brain-derived neurotrophic factor mRNA levels are up-regulated in hindlimb skeletal muscle of diabetic rats: effect of denervation. Exp Neurol 1996; 141: 297-303.
22. Fernyhough P, Diemel LT, Tomlinson DR. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998; 41: 300-306
23. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR. Altered neurotrophin mRNA levels in peripheral nerve and skeletal muscle of experimentally diabetic rats. J Neurochem 1995a; 64: 1231-1237
24. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 1995b; 7: 1107-1110
25. Funakoshi H, Frisen J, Barbany G, Timmusk T, Zachrisson O, Verge VM, et al. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993; 123: 455-465
26. Funakoshi H, Belluardo N, Arenas E, Yamamoto Y, Casabona A, Persson H, et al. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 1995; 268: 1495-1499
27. Gonzalez M, Collins WF III. Modulation of motoneuron excitability by brain-derived neurotrophic factor. J Neurophysiol 1997; 77: 502-506
28. Griesbeck O, Parsadanian AS, Sendtner M, Thoenen H. Expression of neurotrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function. J Neurosci Res 1995; 42: 21-33.
29. Ihara C, Shimatsu A, Mizuta H, Murabe H, Nakamura Y, Nakao K. Decreased neurotrophin-3 expression in skeletal muscles of streptozotocin-induced diabetic rats. Neuropeptides 1996; 30: 309-312
30. Kust BM, Copray JC, Brouwer N, Troost D, Boddeke HW. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 2002; 177: 419-427
31. Lee DA, Gross L, Wittrock DA, Windebank AJ. Localization and expression of ciliary neurotrophic factor (CNTF) in postmortem sciatic nerve from patients with motor neuron disease and diabetic neuropathy. J Neuropathol Exp Neurol 1996; 55: 915-923
32. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9-15.
33. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32. (Pubitemid 23305564)
34. Michalski B, Bain JR, Fahnestock M. Long-term changes in neurotrophic factor expression in distal nerve stump following denervation and reinnervation with motor or sensory nerve. J Neurochem 2008; 105: 1244-1252
35. Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J Peripher Nerv Syst 1999; 4: 211-221 (Pubitemid 30035581)
36. Omura T, Sano M, Omura K, Hasegawa T, Doi M, Sawada T, et al. Different expressions of BDNF, NT3, and NT4 in muscle and nerve after various types of peripheral nerve injuries. J Peripher Nerv Syst 2005; 10: 293-300.
37. Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ. Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int Anesthesiol Clin 2006; 44: 21-76.
38. Pradat PF, Kennel P, Naimi-Sadaoui S, Finiels F, Orsini C, Revah F, et al. Continuous delivery of neurotrophin 3 by gene therapy has a neuro-protective effect in experimental models of diabetic and acrylamide neuropathies. Hum Gene Ther 2001; 12: 2237-2249
39. Sakuma K, Watanabe K, Sano M, Uramoto I, Nakano H, Li YJ, et al. A possible role for BDNF, NT-4 and TrkB in the spinal cord and muscle of rat subjected to mechanical overload, bupivacaine injection and axotomy. Brain Res 2001; 907: 1-19.
40. Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 2000; 23: 639-645
41. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 1990; 345: 440-441
42. Sendtner M, Gotz R, Holtmann B, Thoenen H. Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J Neurosci 1997; 17: 6999-7006.
43. Sendtner M, Arakawa Y, Stockli KA, Kreutzberg GW, Thoenen H. Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival. J Cell Sci Suppl 1991; 15: 103-109
44. Siegel SG, Patton B, English AW. Ciliary neurotrophic factor is required for motoneuron sprouting. Exp Neurol 2000; 166: 205-212
45. Sobue G, Yamamoto M, Doyu M, Li M, Yasuda T, Mitsuma T. Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem Res 1998; 23: 821-829
46. Stalberg E, Falck B. Clinical motor nerve conduction studies. Methods Clin Neurophysiol 1993; 4: 61-80.
47. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT, et al. Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 2000; 48: 623-629
48. Stuerenburg HJ, Kunze K. Tissue nerve growth factor concentrations in neuromuscular diseases. Eur J Neurol 1998; 5: 487-490 (Pubitemid 28470003)
49. The Diabetic Retinopathy Study Research Group. A modification of the Airlie House classification of diabetic retinopathy (DRS report no. 7). Invest Ophthalmol Vis Sci 1981; 21: 210-226
50. Toft I, Lindal S, Bonaa KH, Jenssen T. Quantitative measurement of muscle fiber composition in a normal population. Muscle Nerve 2003; 28: 101-108
51. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 2008; 9: 36-45.
52. Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res 1996; 21: 929-938
53. Zochodne DW. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve 2007; 36: 144-166